Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
Pharmaceutical Investing 3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
Pharmaceutical Investing 3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer
3D Signatures and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration
Pharmaceutical Investing 3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer
Medical Device Investing 3D Signatures Announces Positive Topline Results of Development Trial Assessing its Telo-HL Test for Hodgkin’s Lymphoma
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma
Pharmaceutical Investing 3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement
Pharmaceutical Investing 3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results
3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement
